← All news
Markets
AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
3 outlets - including Investing, Yahoo and Seekingalpha - are covering this story.
Covered by 3 outlets
All coverage · 4 articles
Investing.com News
·Aug 20, 14:50 UTC
UBS reiterates Buy on Bristol-Myers Squibb stock, $80 target
Yahoo Finance News
·Aug 20, 11:00 UTC
Turn Bristol-Myers Squibb into an Income Machine with This Options Play
Investing.com Canada
·Aug 19, 13:48 UTC
Bristol-Myers Squibb stock hits 52-week high at 68.1 USD
Seeking Alpha
·Aug 19, 13:22 UTC